Advertisement
Millions more Americans have affordable health insurance

Patients Report Improved Care Access, Better Health With ACA

0
Gains seen in how many adults have insurance and a doctor, and say they are in better health
About 10 percent of cases where a drug does serious harm are not reported to the U.S. Food and Drug Administration within the required 15-day period

Delays Noted in the Reporting of Serious Patient Harms to FDA

0
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed
More than a third of colorectal cancers diagnosed in younger patients are caused by inherited gene mutations

35% of Colorectal Cancers in Patients Age ≤35 Are Genetic

0
Study authors recommend that people diagnosed before age 35 get tested
Many young cancer patients -- especially females -- have limited awareness about options to preserve their fertility

Cancer Patients Lack Awareness of Fertility Preservation Options

0
Almost one in three not told cancer treatment might affect future fertility
Eradication of Helicobacter pylori in asymptomatic adults is associated with a reduction in the incidence of gastric cancer

Review: Eradicating H. pylori Cuts Incidence of Gastric Cancer

0
Reduction in the incidence of gastric cancer with tx of asymptomatic, otherwise healthy individuals
As a result of the increasing popularity of high-deductible health care plans

Expansion of High-Deductible Plans to Impact Physician Care

0
Physicians must be able to balance provision of good clinical care with ability to limit costs
For patients with end-stage cancer

Chemotherapy Use Doesn’t Improve QOL Near Death

0
No improvement in quality of life, even for patients with good baseline performance status
Soaring costs for cancer drugs are detrimental to patient care in the United States

Oncologists Offer Strategies for Reducing Cost of Cancer Drugs

0
Suggest letting Medicare negotiate prices; back grassroots movement calling for change
There's more evidence that two classes of generic drugs (aromatase inhibitors and bisphosphonates) reduce the risk of death in postmenopausal women with early breast cancer

Generic Meds Boost Survival in Some Early Breast Cancers

0
Researchers found benefit from aromatase inhibitors and bisphosphonates
Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat locally advanced basal cell carcinoma that has returned despite surgery or radiation. The treatment is sanctioned for people who are not candidates for additional surgery or radiation.

FDA Approves Odomzo for Recurring Basal Cell Carcinoma

0
Medication is designed to inhibit the Hedgehog pathway